Rasmus Rask Kragh Jørgensen

9PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersSocial epidemiologyDeep learningEpidemiological methodsProsthetics and orthotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 04, 2026
Development and Validation of a Novel Conditional Event-Free Survival Tool in Diffuse Large B-Cell Lymphoma.

|Mar 30, 2026
Incidence and Survival of Hemophagocytic Lymphohistiocytosis Over Two Decades: A Population-Based Study.

Mads Okkels Birk Lorenzen, Martin Jensen, Rasmus Rask Kragh Jørgensen

|Dec 08, 2025
Validation of US Consensus Eligibility Criteria for Front-Line DLBCL Trials.

Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric

|May 26, 2025
Development of time to event prediction models using federated learning.

Rasmus Rask Kragh Jørgensen, Jonas Faartoft Jensen, Tarec El-Galaly

|May 22, 2025
Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma.

Leo Meriranta, Rasmus Rask Kragh Jørgensen, Annika Pasanen

|Jul 22, 2024
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based study.

Rasmus Rask Kragh Jørgensen, Lasse Hjort Jakobsen, Sandra Eloranta

Pageof 2

Frequent Collaborators

3 joint publications

Martin Hutchings

3 joint publications

Tarec Christoffer El-Galaly

3 joint publications

Ingrid Glimelius

2 joint publications

Leo Meriranta